Mainz Biomed Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Mainz Biomed N.V. (MYNZ) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-21.65-26.30-0.17-11.69-0.59
Depreciation & Amortization1.020.870.380.070.06
Stock Based Compensation1.144.019.826.430.00
Change in Working Capital0.05-0.061.44-0.140.06
Change in Accounts Receivable0.060.02-0.210.02-0.10
Change in Inventory0.03-0.50-0.170.000.00
Change in Accounts Payable0.080.721.650.660.16
Change in Other Working Capital0.01-0.24-0.05-0.830.00
Other Operating Activities2.40-0.46-16.502.110.00
Net Cash from Operating Activities-17.09-21.94-14.77-3.22-0.47
Investing Activities
Capital Expenditures-0.10-1.200.66-0.02-0.01
Acquisitions0.030.000.001.220.00
Sales/Maturities of Investments-0.15-0.700.000.000.00
Other Investing Activities-0.130.000.000.000.00
Net Cash from Investing Activities-0.20-1.90-0.661.20-0.01
Financing Activities
Debt Repayment-1.48-2.29-0.30-0.06-0.04
Common Stock Issued13.766.3923.8710.430.00
Net Cash from Financing Activities16.6014.2323.9410.610.40
Summary
Effect of Forex Changes on Cash-0.15-0.46-0.100.010.00
Net Change in Cash-0.84-10.078.318.60-0.08
Cash at Beginning of Period7.0717.148.730.120.00
Cash at End of Period6.247.0717.148.730.00
Free Cash Flow-17.19-23.14-15.43-3.24-0.48
Supplemental Disclosures
Interest Paid0.200.150.130.050.02